Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Zewdie MekonnenDepartment of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa P. O. Box 9086, Ethiopia.ORCID 0000-0002-0521-0213
Giuseppe PetitoDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, 81100 Caserta, Italy.ORCID 0009-0006-5470-0354
Getasew ShitayeDepartment of Biomedical Sciences, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar P. O. Box 79, Ethiopia.ORCID 0000-0003-3114-5029
Gianluca D'AbroscaDepartment of Clinical and Experimental Medicine, University of Foggia, Viale Pinto 1, 71100 Foggia, Italy.ORCID 0000-0002-1786-4249
Belete Adefris LegesseCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa P. O. Box 9086, Ethiopia.ORCID 0000-0002-1402-9221
Sisay AddisuDepartment of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa P. O. Box 9086, Ethiopia.ORCID 0000-0001-9713-8791
Maurizio RagniCenter for Study and Research on Obesity, Department of Medical Biotechnology and Translational Medicine, University of Milan, 20133 Milan, Italy.ORCID 0000-0001-6548-741X
Antonia LanniDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, 81100 Caserta, Italy.ORCID 0000-0001-5797-0348
Roberto FattorussoDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, 81100 Caserta, Italy.ORCID 0000-0002-3539-5343
Carla IserniaDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, 81100 Caserta, Italy.ORCID 0000-0002-1504-2479
Lara ComuneDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, 81100 Caserta, Italy.
Simona PiccolellaDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, 81100 Caserta, Italy.ORCID 0000-0003-3150-7886
Severina PacificoDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, 81100 Caserta, Italy.ORCID 0000-0002-3804-9809
Rosalba SeneseDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, 81100 Caserta, Italy.ORCID 0000-0003-1571-0980
Gaetano MalgieriDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, 81100 Caserta, Italy.ORCID 0000-0002-4070-9458
Solomon Tebeje GizawDepartment of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa P. O. Box 9086, Ethiopia.ORCID 0000-0001-5281-8611
Funding
Italian Ministry of University PRIN2022PNRR (P2022AW2H9)
6 · The paper itself
Abstract
Type 2 diabetes mellitus (T2DM) is a chronic disease characterized by insulin resistance and impaired beta-cell secretory function. Since existing treatments often present side effects based on different mechanisms, alternative therapeutic options are needed. In this scenario, the present study first evaluates the cytotoxicity of decoctions from the leaves, stems, and roots of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.